|
Delayed
NSE India S.E.
12:05:07 01/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 421.00 INR | -2.30% |
|
-3.72% | +2.27% |
| 09-26 | Aarti Drugs Limited Announces Board Appointments | CI |
| 09-26 | Aarti Drugs Limited Appoints Shri Adhish Prakash Patil as Managing Director | CI |
| Market Cap | 38.52B 400M 355M 332M 303M 570M 578M 4.02B 1.56B 19.62B 1.5B 1.47B 63.01B | P/E 2027 * |
-
| P/E 2028 * | 15.1x |
|---|---|---|---|---|---|
| Enterprise Value | 38.52B 400M 355M 332M 303M 570M 578M 4.02B 1.56B 19.62B 1.5B 1.47B 63.01B | EV / Sales 2027 * |
1.31x | EV / Sales 2028 * | 1.18x |
| Free-Float |
40.44% | Yield 2027 * |
1.4% | Yield 2028 * | 1.66% |
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| AARTIDRUGS | Delayed | |
NSE India S.E.
| AARTIDRUGS | Delayed |
Last Transcript: Aarti Drugs Limited
| 28/12/22 | Aarti Drugs : Loss of Share Certificates | PU |
| 10/07/22 | Aarti Drugs : Newspaper Advertisements | PU |
| 1 day | -2.30% | ||
| 1 week | -3.72% | ||
| Current month | -2.30% | ||
| 1 month | -1.43% | ||
| 3 months | +12.10% | ||
| 6 months | +21.54% | ||
| Current year | +2.27% |
| 1 week | 414.3 |  | 444 |
| 1 month | 411 | | 450.2 |
| Current year | 318.95 | | 453.65 |
| 1 year | 318.95 | | 534 |
| 3 years | 312 | | 635 |
| 5 years | 312 | | 645.75 |
| 10 years | 105.25 | | 1,026.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 80 | - | |
| Chief Tech/Sci/R&D Officer | - | - | |
| Compliance Officer | - | 22/04/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 31/05/2007 | |
| Chairman | 80 | - | |
| Director/Board Member | 63 | 01/01/1987 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.30% | -3.72% | - | - | 400M | |
| -0.62% | -2.71% | +39.30% | +114.07% | 1,025B | |
| -2.30% | -4.44% | +39.03% | +66.07% | 623B | |
| -0.63% | -1.96% | +6.36% | +74.38% | 459B | |
| -1.03% | -2.82% | +59.56% | +39.69% | 355B | |
| -0.49% | -3.77% | +21.95% | +39.77% | 336B | |
| +0.17% | -1.44% | +13.52% | +26.46% | 270B | |
| +0.10% | -4.22% | -3.47% | +9.79% | 247B | |
| -3.38% | +0.30% | +36.44% | +51.54% | 220B | |
| -1.04% | -1.46% | +32.70% | +96.82% | 183B | |
| Average | -1.16% | -1.89% | +27.27% | +57.62% | 413.14B | |
| Weighted average by Cap. | -1.02% | -2.11% | +30.35% | +69.48% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 29.45B 306M 272M 254M 232M 436M 442M 3.07B 1.19B 15B 1.15B 1.12B 48.18B | 32.69B 339M 302M 282M 257M 484M 490M 3.41B 1.32B 16.65B 1.27B 1.25B 53.47B |
| Net income | 2.15B 22.35M 19.85M 18.57M 16.92M 31.85M 32.29M 225M 86.94M 1.1B 83.92M 82.1M 3.52B | 2.55B 26.44M 23.49M 21.96M 20.02M 37.68M 38.2M 266M 103M 1.3B 99.28M 97.13M 4.16B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/10/26 | ₹421.00 | -2.30% | 171,972 |
| 30/09/26 | ₹430.90 | +0.54% | 145,119 |
| 29/09/26 | ₹428.60 | -0.24% | 570,194 |
| 28/09/26 | ₹429.65 | +0.53% | 442,110 |
| 25/09/26 | ₹427.40 | -2.25% | 212,626 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AARTIDRUGS Stock
- AARTIDRUGS Stock
Select your edition
All financial news and data tailored to specific country editions
